← Back to headlines
FDA Accepts Roche Application for Lupus Treatment Gazyva/Gazyvaro
The U.S. Food and Drug Administration has accepted Roche's application for its drug Gazyva/Gazyvaro, intended for the treatment of common lupus.
21 Apr, 05:22 — 21 Apr, 05:22
Sources
Showing 1 of 1 sources
Related Stories
Norway Mourns King Harald V as Crown Prince Haakon Ascends the Throne
11m ago
Zelensky Directs Ukrainian Military to Launch 1,000 Drones Daily Against Russia
27m ago
EU Condemns Glorification of Ratko Mladić Amid Deepening Bosnian Divisions
36m ago
U.S. Sanctions Target Iranian Dollar Access as Conflict Reaches Six Months
37m ago